Tech Company Financing Transactions
Frequency Therapeutics Funding Round
Frequency Therapeutics, operating out of Woburn, received $32 million from Cobro Ventures, Alexandria Venture Investments and Korea Investment Partners.
Transaction Overview
Company Name
Announced On
4/12/2017
Transaction Type
Venture Equity
Amount
$32,000,000
Round
Series A
Investors
Cobro Ventures (Lead Investor) (Marc Cohen)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
19 Presidential Way
Woburn, MA 01801
USA
Woburn, MA 01801
USA
Phone
Website
Email Address
Overview
Frequency Therapeutics (Nasdaq: FREQ) develops small molecule drugs that activate progenitor cells within the body to restore healthy tissue. Through the transitory activation of these progenitor cells, Frequency enables disease modification without the complexity of genetic engineering.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
David Lucchino
Chief Medical Officer
William Chin
Chief Scientific Officer
Chris Loose
Vice President
William Mclean
VP - Bus. Development
Carl Lebel
VP - Bus. Development
Ajay Rai
VP - R & D
Scott Eliasof
Browse more venture capital transactions:
Prev: 4/12/2017: Lybrate venture capital transaction
Next: 4/12/2017: Spring Health venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to report on funding rounds that are announced publicly. VC transactions on this site are derived from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs